LivaNova PLC (FRA:LIA)

Market Cap	2.94B +52.2%
Revenue (ttm)	1.18B +10.7%
Net Income	-206.51M
EPS	-3.79
Shares Out	n/a
PE Ratio	n/a
Forward PE	14.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	55.50
Previous Close	54.00
Day's Range	55.50 - 55.50
52-Week Range	29.60 - 59.50
Beta	n/a
RSI	53.70
Earnings Date	May 6, 2026

About LivaNova

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing sy...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Employees: 3,300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LIA

Financial Performance

Financial numbers in USD